US 9,993,550 B2Granted

Treatment of pemphigus

AssigneesGenentech, Inc., Biogen Idec Inc.

InventorsJohn G. Curd, Antonio J. Grillo-Lopez

Life of this patent

Estimating the term…

Abstract

The present invention concerns treatment of pemphigus with an antibody which binds to CD20.

Claims7

Dependent claims

A method of treating pemphigus in a human who does not have an autoimmune disease other than pemphigus comprising administering to the human a therapeutically effective amount of rituximab.

Dependencies are inferred from the claim text.

Facts

Application: 14/801,267Filed 16 Jul 2015 · division
Priority: 7 May 1999
Published: US 2016/0175435 A123 Jun 2016
Granted: 12 Jun 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification51 codes

A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61K 31/56
Medicinal preparations containing organic active ingredients: compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application60/133,018Us provisional application · filed 7 May 1999
Application60/139,621Us provisional application · filed 17 Jun 1999
Application09/564,288Parent of this division · filed 4 May 2000
Application12/886,171Parent of this division · filed 20 Sep 2010
US 7,820,161 B1Parent of this division · filed 26 Oct 2010
Application13/969,276Parent of this division · filed 16 Aug 2013
US 8,545,843 B2Parent of this division · filed 1 Oct 2013
US 2016/0175435 A1Pre-grant publication · published 23 Jun 2016
US 2011/0008337 A1Published application
US 2013/0330332 A1Published application
US 9,993,550 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Facts

Application

14/801,267Filed 16 Jul 2015 · division

Priority

7 May 1999

Published

US 2016/0175435 A123 Jun 2016

Granted

12 Jun 2018

Term ends

Not estimatedThe source records don’t support an estimate.

Classification51 codes

A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61K 31/56
Medicinal preparations containing organic active ingredients: compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application60/133,018Us provisional application · filed 7 May 1999

Application60/139,621Us provisional application · filed 17 Jun 1999

Application09/564,288Parent of this division · filed 4 May 2000

Application12/886,171Parent of this division · filed 20 Sep 2010

US 7,820,161 B1Parent of this division · filed 26 Oct 2010

Application13/969,276Parent of this division · filed 16 Aug 2013

US 8,545,843 B2Parent of this division · filed 1 Oct 2013

US 2016/0175435 A1Pre-grant publication · published 23 Jun 2016

US 2011/0008337 A1Published application

US 2013/0330332 A1Published application

US 9,993,550 B2This patent

From the US filing history. Foreign family members aren’t listed.